FRASSOLDATI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 85
EU - Europa 67
AS - Asia 43
AF - Africa 9
OC - Oceania 1
Totale 205
Nazione #
US - Stati Uniti d'America 83
IT - Italia 29
SG - Singapore 20
CN - Cina 13
SE - Svezia 10
DE - Germania 6
GB - Regno Unito 5
IN - India 5
CI - Costa d'Avorio 4
IE - Irlanda 4
RU - Federazione Russa 4
TG - Togo 4
CH - Svizzera 3
FI - Finlandia 3
CA - Canada 2
JO - Giordania 2
NL - Olanda 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
HK - Hong Kong 1
NG - Nigeria 1
Totale 205
Città #
Singapore 19
Chandler 17
Santa Clara 8
Ashburn 6
Bagnacavallo 6
Abidjan 4
Boardman 4
Bologna 4
Dublin 4
Fairfield 4
Lomé 4
Milan 4
Southend 4
Bentivoglio 3
Helsinki 3
Los Angeles 3
Princeton 3
Amman 2
Bern 2
Moscow 2
Naples 2
Treviso 2
Turin 2
Abeokuta 1
Beijing 1
Berlin 1
Bremen 1
Bühl 1
Cambridge 1
Chicago 1
Chongqing 1
Des Moines 1
Florence 1
Hangzhou 1
Hong Kong 1
Jinan 1
Leawood 1
Leicester 1
Melbourne 1
Nanyang 1
Olalla 1
Ottawa 1
Redmond 1
Saint Louis 1
San Diego 1
Seattle 1
Shanwei 1
Shijiazhuang 1
Sofia 1
Toronto 1
Washington 1
Wilmington 1
Xi'an 1
Totale 142
Nome #
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5] 96
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 65
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET 32
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) 20
Totale 213
Categoria #
all - tutte 911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 4 0 0 1
2021/202243 0 0 1 4 3 1 0 11 2 4 11 6
2022/202351 3 7 1 8 4 5 1 2 10 2 5 3
2023/202432 1 4 1 13 2 6 1 1 1 0 2 0
2024/202582 8 13 11 9 17 10 13 1 0 0 0 0
Totale 213